New cholesterol drug passes early safety check in healthy volunteers
NCT ID NCT06857253
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new drug called HRS-1301 in 82 healthy adults to check its safety and how the body processes it. The goal is to see if it can help control high cholesterol. Participants received either the drug or a placebo, and researchers monitored for side effects and drug levels in blood and urine.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can two experimental pills work together safely? a trial seeks answers
- Can a new pill tame high cholesterol? a phase 1 trial puts SAL0167 to the test
- Gut bacteria may tame pancreatitis — probiotic combo put to the test
- Fatty meals may trap vitamin e in the blood, study suggests
- Could vinegar and fasting fix prediabetes cholesterol?
- Could a monthly shot beat biweekly for lowering cholesterol?